Relmada Therapeutics, Inc. (RLMD)

NASDAQ: RLMD · IEX Real-Time Price · USD
3.00
+0.06 (2.04%)
Sep 29, 2023, 9:36 AM EDT - Market open

Ratios and Metrics (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year Current20222021202020192018201720162015
Market Capitalization
90105395521401131027-
Market Cap Growth
--73.40%-24.17%29.98%3061.80%28.38%-63.97%--
Enterprise Value
-24-4318340428413819-22
PE Ratio
-0.57-0.67-3.14-8.76-26.71-1.41-1.57-9.21-
PB Ratio
0.850.751.904.933.46-2.306.763.89-
P/FCF Ratio
-0.80-1.01-4.30-18.73-33.14-2.11-1.52-2.00-
P/OCF Ratio
-0.80-1.01-4.30-18.73-33.14-2.11-1.53-2.08-
EV/EBITDA Ratio
0.340.28-1.46-6.79-19.09-1.76-1.36-6.571.07
EV/EBIT Ratio
0.340.28-1.46-6.79-19.09-1.75-1.34-6.451.07
EV/FCF Ratio
0.480.42-1.99-14.52-23.52-2.22-1.30-1.401.37
Debt / Equity Ratio
----0.00-0.530.190.040.03
Debt / EBITDA Ratio
-----0.01-0.39-0.04-0.09-0.01
Debt / FCF Ratio
-----0.01-0.49-0.04-0.02-0.02
Quick Ratio
11.0711.9414.089.3080.040.441.702.851.44
Current Ratio
11.4012.2614.839.3780.210.461.803.041.54
Interest Coverage
-----143.13-5.70-11429.04-1701.74-
Return on Equity (ROE)
-94.90%-88.00%-107.30%-50.30%-46.30%635.20%-173.30%-27.80%-
Return on Assets (ROA)
-86.30%-80.40%-95.10%-48.20%-43.30%-178.90%-118.90%-19.80%-
Return on Capital (ROIC)
-114.10%-107.60%-124.30%-54.40%-79.40%312.20%-25656.00%113.80%-
Earnings Yield
-136.04%-149.50%-31.84%-11.41%-3.74%-70.70%-63.68%-10.86%-
FCF Yield
-97.59%-98.82%-23.26%-5.34%-3.02%-47.45%-66.00%-50.02%-
Buyback Yield / Dilution
-0.55%-68.80%-12.56%-68.75%-194.65%-3.90%-4.10%-16.68%-
Total Shareholder Return
-0.55%-68.80%-12.56%-68.75%-194.65%-3.90%-4.10%-16.68%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).